StockData
Embecta Corp. logo

Embecta Corp. (EMBC) stock

EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3080% below fair value
$6.15−0.10 (-1.60%)

Close on Nov 17, 2026Market cap $348.46MP/E 4.2Yield 9.76%

Embecta operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Embecta's operating income for the twelve months ending Jun 30, 2026 was $223.50M, up 5.5% year over year. For fiscal 2025 it was $242.10M, up 45.1% from the year before. The highest annual figure on record is $492.00M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025$242.10M+45.1%
FY2024Sep 30, 2024$166.80M-24.7%
FY2023Sep 30, 2023$221.50M-28.5%
FY2022Sep 30, 2022$309.60M-37.1%
FY2021Sep 30, 2021$492.00M+1.1%
FY2020Sep 30, 2020$486.50M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$48.70M-48.2%
Q2 FY2026CQ1 2026Mar 31, 2026$35.00M-44.4%
Q1 FY2026CQ4 2025Dec 31, 2025$83.30M+190.2%
Q4 FY2025CQ3 2025Sep 30, 2025$56.50M+115.6%
Q3 FY2025CQ2 2025Jun 30, 2025$94.00M+68.2%
Q2 FY2025CQ1 2025Mar 31, 2025$62.90M+60.5%
Q1 FY2025CQ4 2024Dec 31, 2024$28.70M-36.9%
Q4 FY2024CQ3 2024Sep 30, 2024$26.20M+1.6%
Q3 FY2024CQ2 2024Jun 30, 2024$55.90M+9.0%
Q2 FY2024CQ1 2024Mar 31, 2024$39.20M-29.5%
Q1 FY2024CQ4 2023Dec 31, 2023$45.50M-48.8%
Q4 FY2023CQ3 2023Sep 30, 2023$25.80M–
Q3 FY2023CQ2 2023Jun 30, 2023$51.30M-47.2%
Q2 FY2023CQ1 2023Mar 31, 2023$55.60M-43.8%
Q1 FY2023CQ4 2022Dec 31, 2022$88.80M-23.8%
Q4 FY2022CQ3 2022Sep 30, 2022-$3.00M-102.6%
Q3 FY2022CQ2 2022Jun 30, 2022$97.10M-21.9%
Q2 FY2022CQ1 2022Mar 31, 2022$98.90M-21.8%
Q1 FY2022CQ4 2021Dec 31, 2021$116.60M-6.0%
Q4 FY2021CQ3 2021Sep 30, 2021$117.20M–
Q3 FY2021CQ2 2021Jun 30, 2021$124.30M–
Q2 FY2021CQ1 2021Mar 31, 2021$126.40M–
Q1 FY2021CQ4 2020Dec 31, 2020$124.10M–

More Embecta figures

See a number that looks wrong?